| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autoimmunity | 82 | 2025 | 908 | 10.770 |
Why?
|
| Diabetes Mellitus, Type 1 | 125 | 2025 | 3709 | 8.700 |
Why?
|
| Islets of Langerhans | 60 | 2025 | 803 | 8.670 |
Why?
|
| Autoantibodies | 99 | 2025 | 1500 | 7.370 |
Why?
|
| Arthritis, Rheumatoid | 51 | 2025 | 1164 | 6.730 |
Why?
|
| Vitamin D | 24 | 2024 | 395 | 4.120 |
Why?
|
| Diet | 30 | 2024 | 1273 | 4.040 |
Why?
|
| Rheumatoid Factor | 23 | 2025 | 175 | 3.700 |
Why?
|
| Anti-Citrullinated Protein Antibodies | 15 | 2025 | 115 | 3.670 |
Why?
|
| Genetic Predisposition to Disease | 74 | 2025 | 2417 | 3.550 |
Why?
|
| Fatty Acids, Omega-3 | 13 | 2020 | 139 | 3.540 |
Why?
|
| Celiac Disease | 23 | 2024 | 293 | 3.510 |
Why?
|
| DNA Methylation | 7 | 2025 | 644 | 3.390 |
Why?
|
| Lupus Erythematosus, Systemic | 9 | 2022 | 257 | 2.640 |
Why?
|
| Polymorphism, Single Nucleotide | 64 | 2025 | 2190 | 2.440 |
Why?
|
| Risk Factors | 111 | 2025 | 10331 | 2.430 |
Why?
|
| Glutens | 11 | 2023 | 59 | 2.380 |
Why?
|
| Child, Preschool | 108 | 2024 | 11069 | 2.200 |
Why?
|
| Peptides, Cyclic | 21 | 2023 | 259 | 2.160 |
Why?
|
| Genome-Wide Association Study | 31 | 2025 | 1434 | 2.150 |
Why?
|
| Erythrocyte Membrane | 6 | 2015 | 55 | 2.110 |
Why?
|
| Female | 283 | 2025 | 72840 | 2.060 |
Why?
|
| Male | 267 | 2025 | 67361 | 2.040 |
Why?
|
| Disease Progression | 31 | 2024 | 2750 | 2.030 |
Why?
|
| Infant | 107 | 2024 | 9442 | 2.020 |
Why?
|
| Insulin Resistance | 46 | 2023 | 1201 | 1.960 |
Why?
|
| Prospective Studies | 73 | 2025 | 7583 | 1.950 |
Why?
|
| Breast Feeding | 22 | 2021 | 439 | 1.880 |
Why?
|
| Child | 124 | 2025 | 21968 | 1.840 |
Why?
|
| Humans | 365 | 2025 | 136783 | 1.840 |
Why?
|
| Diabetes Mellitus, Type 2 | 39 | 2025 | 2512 | 1.770 |
Why?
|
| Adiposity | 21 | 2017 | 518 | 1.650 |
Why?
|
| Family | 23 | 2023 | 666 | 1.590 |
Why?
|
| Vitamin D Deficiency | 7 | 2018 | 184 | 1.570 |
Why?
|
| Oxylipins | 3 | 2023 | 40 | 1.550 |
Why?
|
| Genotype | 53 | 2023 | 1919 | 1.470 |
Why?
|
| Milk | 12 | 2018 | 124 | 1.460 |
Why?
|
| Infant Nutritional Physiological Phenomena | 8 | 2021 | 144 | 1.410 |
Why?
|
| Infant Food | 9 | 2018 | 65 | 1.330 |
Why?
|
| HLA-DR Antigens | 16 | 2024 | 228 | 1.310 |
Why?
|
| Case-Control Studies | 39 | 2025 | 3537 | 1.300 |
Why?
|
| Middle Aged | 123 | 2025 | 33200 | 1.220 |
Why?
|
| Follow-Up Studies | 43 | 2024 | 5115 | 1.210 |
Why?
|
| Cohort Studies | 54 | 2022 | 5718 | 1.180 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2021 | 98 | 1.160 |
Why?
|
| Atherosclerosis | 19 | 2023 | 415 | 1.160 |
Why?
|
| Proportional Hazards Models | 20 | 2024 | 1260 | 1.160 |
Why?
|
| Adiponectin | 11 | 2018 | 243 | 1.150 |
Why?
|
| Dietary Proteins | 7 | 2019 | 135 | 1.140 |
Why?
|
| Prenatal Exposure Delayed Effects | 9 | 2025 | 607 | 1.130 |
Why?
|
| Insulin | 30 | 2021 | 2399 | 1.130 |
Why?
|
| Adult | 132 | 2025 | 37616 | 1.110 |
Why?
|
| Eating | 6 | 2023 | 378 | 1.090 |
Why?
|
| HLA-DR4 Antigen | 11 | 2021 | 78 | 1.080 |
Why?
|
| Longitudinal Studies | 22 | 2025 | 2847 | 1.050 |
Why?
|
| Body Mass Index | 32 | 2023 | 2364 | 1.020 |
Why?
|
| Dietary Sucrose | 2 | 2020 | 49 | 1.000 |
Why?
|
| Biomarkers | 26 | 2024 | 4158 | 1.000 |
Why?
|
| Adolescent | 69 | 2025 | 21463 | 0.970 |
Why?
|
| Smoking | 10 | 2025 | 1633 | 0.930 |
Why?
|
| Infant, Newborn | 51 | 2022 | 6046 | 0.910 |
Why?
|
| Surveys and Questionnaires | 25 | 2024 | 5749 | 0.910 |
Why?
|
| Bacteroidaceae Infections | 4 | 2012 | 7 | 0.890 |
Why?
|
| Seroconversion | 2 | 2021 | 46 | 0.870 |
Why?
|
| Obesity | 22 | 2021 | 2975 | 0.830 |
Why?
|
| Transglutaminases | 14 | 2024 | 156 | 0.820 |
Why?
|
| Colorado | 38 | 2024 | 4491 | 0.820 |
Why?
|
| Environmental Exposure | 6 | 2025 | 576 | 0.820 |
Why?
|
| Cat Diseases | 6 | 2011 | 21 | 0.820 |
Why?
|
| Metabolic Syndrome | 6 | 2021 | 354 | 0.800 |
Why?
|
| Edible Grain | 5 | 2013 | 49 | 0.800 |
Why?
|
| Docosahexaenoic Acids | 5 | 2021 | 84 | 0.790 |
Why?
|
| Antibodies, Bacterial | 5 | 2025 | 146 | 0.780 |
Why?
|
| Blood Glucose | 19 | 2021 | 2180 | 0.770 |
Why?
|
| Infant Formula | 5 | 2019 | 75 | 0.770 |
Why?
|
| Porphyromonas gingivalis | 4 | 2012 | 23 | 0.770 |
Why?
|
| Mass Screening | 10 | 2024 | 1262 | 0.760 |
Why?
|
| Incidence | 22 | 2023 | 2788 | 0.760 |
Why?
|
| HLA-DR3 Antigen | 9 | 2023 | 80 | 0.740 |
Why?
|
| Child Nutritional Physiological Phenomena | 4 | 2019 | 107 | 0.740 |
Why?
|
| Pregnancy | 31 | 2025 | 6731 | 0.730 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2021 | 46 | 0.730 |
Why?
|
| Epitopes | 5 | 2022 | 480 | 0.710 |
Why?
|
| Autoimmune Diseases | 8 | 2019 | 459 | 0.700 |
Why?
|
| Mexican Americans | 6 | 2024 | 117 | 0.700 |
Why?
|
| Periodontitis | 3 | 2012 | 52 | 0.700 |
Why?
|
| F2-Isoprostanes | 2 | 2015 | 21 | 0.690 |
Why?
|
| Micronutrients | 5 | 2024 | 93 | 0.690 |
Why?
|
| HLA-DQ Antigens | 14 | 2018 | 181 | 0.680 |
Why?
|
| Fatty Acids, Omega-6 | 5 | 2020 | 47 | 0.670 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 7 | 2021 | 175 | 0.670 |
Why?
|
| Metabolomics | 5 | 2023 | 679 | 0.660 |
Why?
|
| Age Factors | 27 | 2024 | 3290 | 0.660 |
Why?
|
| Receptors, Calcitriol | 4 | 2016 | 55 | 0.650 |
Why?
|
| Inflammation Mediators | 4 | 2020 | 514 | 0.650 |
Why?
|
| Sugars | 1 | 2020 | 41 | 0.650 |
Why?
|
| Overweight | 6 | 2021 | 557 | 0.650 |
Why?
|
| Dietary Supplements | 9 | 2024 | 559 | 0.630 |
Why?
|
| Phospholipids | 1 | 2021 | 222 | 0.630 |
Why?
|
| Gene Frequency | 17 | 2021 | 520 | 0.630 |
Why?
|
| Immunoglobulin A | 10 | 2024 | 210 | 0.630 |
Why?
|
| Genetic Variation | 9 | 2017 | 985 | 0.620 |
Why?
|
| Genome, Human | 9 | 2021 | 424 | 0.620 |
Why?
|
| Aged | 54 | 2025 | 23729 | 0.610 |
Why?
|
| Phenotype | 29 | 2021 | 3199 | 0.610 |
Why?
|
| Alleles | 15 | 2021 | 888 | 0.600 |
Why?
|
| Immunoglobulin G | 8 | 2023 | 886 | 0.590 |
Why?
|
| Family Health | 12 | 2017 | 197 | 0.590 |
Why?
|
| Milk Proteins | 3 | 2008 | 34 | 0.590 |
Why?
|
| Ascorbic Acid | 5 | 2024 | 126 | 0.590 |
Why?
|
| Polymorphism, Genetic | 11 | 2021 | 657 | 0.580 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2018 | 68 | 0.560 |
Why?
|
| Glutamate Decarboxylase | 12 | 2021 | 170 | 0.550 |
Why?
|
| HLA Antigens | 14 | 2019 | 237 | 0.550 |
Why?
|
| Genetic Linkage | 11 | 2016 | 298 | 0.550 |
Why?
|
| Genetic Loci | 8 | 2020 | 288 | 0.530 |
Why?
|
| PPAR gamma | 3 | 2016 | 182 | 0.520 |
Why?
|
| Feline Acquired Immunodeficiency Syndrome | 1 | 2016 | 2 | 0.520 |
Why?
|
| Vitamin D3 24-Hydroxylase | 1 | 2016 | 15 | 0.520 |
Why?
|
| Quantitative Trait, Heritable | 3 | 2021 | 126 | 0.520 |
Why?
|
| Arachidonic Acid | 2 | 2021 | 120 | 0.510 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 8 | 2019 | 46 | 0.510 |
Why?
|
| Intra-Abdominal Fat | 11 | 2021 | 91 | 0.510 |
Why?
|
| Cytokines | 7 | 2020 | 2088 | 0.510 |
Why?
|
| Dietary Carbohydrates | 2 | 2015 | 154 | 0.500 |
Why?
|
| Epigenesis, Genetic | 5 | 2024 | 658 | 0.500 |
Why?
|
| Multivariate Analysis | 13 | 2021 | 1513 | 0.500 |
Why?
|
| Population Surveillance | 5 | 2015 | 470 | 0.500 |
Why?
|
| Diet Surveys | 7 | 2021 | 95 | 0.490 |
Why?
|
| Carbohydrates | 2 | 2015 | 66 | 0.490 |
Why?
|
| Sputum | 4 | 2021 | 311 | 0.490 |
Why?
|
| Homeostasis | 15 | 2023 | 618 | 0.490 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 6 | 2023 | 278 | 0.490 |
Why?
|
| Feeding Methods | 1 | 2015 | 6 | 0.480 |
Why?
|
| Diabetes, Gestational | 7 | 2020 | 316 | 0.480 |
Why?
|
| Air Pollution | 2 | 2024 | 315 | 0.480 |
Why?
|
| Viral Vaccines | 1 | 2016 | 98 | 0.470 |
Why?
|
| Feeding Behavior | 4 | 2018 | 648 | 0.470 |
Why?
|
| Child Day Care Centers | 1 | 2015 | 34 | 0.470 |
Why?
|
| GTP-Binding Proteins | 6 | 2024 | 161 | 0.460 |
Why?
|
| Interprofessional Relations | 1 | 2017 | 280 | 0.460 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 443 | 0.440 |
Why?
|
| Chemokines | 2 | 2012 | 228 | 0.440 |
Why?
|
| Pedigree | 12 | 2020 | 514 | 0.440 |
Why?
|
| United States | 45 | 2025 | 14660 | 0.430 |
Why?
|
| Altitude | 1 | 2018 | 482 | 0.430 |
Why?
|
| Alberta | 4 | 2022 | 27 | 0.430 |
Why?
|
| Glucose | 11 | 2023 | 1019 | 0.430 |
Why?
|
| Dietary Fats, Unsaturated | 3 | 2011 | 23 | 0.430 |
Why?
|
| Joints | 3 | 2013 | 105 | 0.430 |
Why?
|
| CpG Islands | 3 | 2023 | 159 | 0.430 |
Why?
|
| Sleep | 2 | 2018 | 751 | 0.420 |
Why?
|
| Dog Diseases | 3 | 2025 | 62 | 0.420 |
Why?
|
| Diet Records | 5 | 2019 | 83 | 0.420 |
Why?
|
| Dietary Fats | 3 | 2011 | 303 | 0.420 |
Why?
|
| Fatty Acid Desaturases | 1 | 2013 | 32 | 0.420 |
Why?
|
| Quantitative Trait Loci | 10 | 2025 | 381 | 0.420 |
Why?
|
| Blood Pressure | 8 | 2020 | 1772 | 0.420 |
Why?
|
| Energy Intake | 7 | 2023 | 484 | 0.410 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2007 | 285 | 0.410 |
Why?
|
| Social Responsibility | 1 | 2013 | 51 | 0.410 |
Why?
|
| Pregnancy in Diabetics | 4 | 2012 | 122 | 0.410 |
Why?
|
| Genetic Association Studies | 7 | 2020 | 376 | 0.410 |
Why?
|
| Psychometrics | 2 | 2017 | 721 | 0.410 |
Why?
|
| Genetic Testing | 9 | 2020 | 452 | 0.410 |
Why?
|
| Probiotics | 3 | 2019 | 53 | 0.400 |
Why?
|
| Stress, Psychological | 2 | 2020 | 1098 | 0.400 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2012 | 11 | 0.400 |
Why?
|
| Pediatrics | 2 | 2020 | 1112 | 0.390 |
Why?
|
| Vaccination | 2 | 2022 | 1378 | 0.390 |
Why?
|
| C-Reactive Protein | 6 | 2018 | 411 | 0.380 |
Why?
|
| Risk Assessment | 13 | 2020 | 3429 | 0.380 |
Why?
|
| Nurse's Role | 1 | 2013 | 150 | 0.370 |
Why?
|
| Fluorocarbons | 2 | 2023 | 117 | 0.370 |
Why?
|
| Europe | 13 | 2020 | 414 | 0.370 |
Why?
|
| Membrane Proteins | 8 | 2025 | 1162 | 0.370 |
Why?
|
| Texas | 9 | 2014 | 246 | 0.370 |
Why?
|
| Exome | 4 | 2021 | 231 | 0.370 |
Why?
|
| Cross-Sectional Studies | 12 | 2022 | 5417 | 0.370 |
Why?
|
| Nursing Staff, Hospital | 1 | 2013 | 153 | 0.370 |
Why?
|
| Calcifediol | 1 | 2011 | 33 | 0.370 |
Why?
|
| Workplace | 1 | 2013 | 259 | 0.360 |
Why?
|
| Age of Onset | 9 | 2018 | 518 | 0.360 |
Why?
|
| Cholesterol, HDL | 5 | 2025 | 203 | 0.360 |
Why?
|
| Young Adult | 26 | 2023 | 13126 | 0.360 |
Why?
|
| Triglycerides | 6 | 2025 | 524 | 0.360 |
Why?
|
| Nutritional Status | 3 | 2013 | 344 | 0.350 |
Why?
|
| RGS Proteins | 1 | 2011 | 18 | 0.350 |
Why?
|
| Waist-Hip Ratio | 3 | 2007 | 39 | 0.350 |
Why?
|
| Logistic Models | 10 | 2019 | 2060 | 0.350 |
Why?
|
| Extracellular Traps | 3 | 2021 | 53 | 0.350 |
Why?
|
| Cats | 8 | 2016 | 209 | 0.340 |
Why?
|
| Food, Fortified | 1 | 2010 | 40 | 0.340 |
Why?
|
| Porphyromonas | 2 | 2001 | 3 | 0.340 |
Why?
|
| Fetal Blood | 5 | 2021 | 327 | 0.340 |
Why?
|
| Animals | 36 | 2025 | 36768 | 0.330 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 939 | 0.330 |
Why?
|
| Antigens, Bacterial | 2 | 2001 | 129 | 0.320 |
Why?
|
| Periodontal Diseases | 2 | 2001 | 60 | 0.320 |
Why?
|
| Diabetes Mellitus | 6 | 2020 | 1033 | 0.320 |
Why?
|
| Food Preferences | 1 | 2011 | 119 | 0.320 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2019 | 849 | 0.320 |
Why?
|
| Exercise | 5 | 2022 | 2038 | 0.320 |
Why?
|
| Body Height | 2 | 2009 | 199 | 0.310 |
Why?
|
| Models, Genetic | 6 | 2017 | 605 | 0.310 |
Why?
|
| HLA-DQ beta-Chains | 7 | 2015 | 63 | 0.310 |
Why?
|
| B-Lymphocytes | 2 | 2025 | 846 | 0.300 |
Why?
|
| Quality Improvement | 1 | 2017 | 1152 | 0.300 |
Why?
|
| Adipose Tissue | 8 | 2017 | 629 | 0.300 |
Why?
|
| Seizures | 2 | 2006 | 430 | 0.300 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2021 | 765 | 0.300 |
Why?
|
| Insulin-Secreting Cells | 5 | 2018 | 372 | 0.300 |
Why?
|
| Th17 Cells | 3 | 2025 | 109 | 0.300 |
Why?
|
| Glycemic Index | 1 | 2008 | 27 | 0.300 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 3 | 2017 | 59 | 0.290 |
Why?
|
| Life Style | 5 | 2015 | 484 | 0.290 |
Why?
|
| Air Pollutants | 2 | 2024 | 427 | 0.290 |
Why?
|
| Calcitriol | 1 | 2008 | 58 | 0.290 |
Why?
|
| Vitamins | 3 | 2024 | 177 | 0.280 |
Why?
|
| Vaccines | 2 | 2023 | 406 | 0.280 |
Why?
|
| Inflammation | 5 | 2022 | 2834 | 0.280 |
Why?
|
| Odds Ratio | 7 | 2019 | 1063 | 0.280 |
Why?
|
| Seroepidemiologic Studies | 5 | 2025 | 163 | 0.280 |
Why?
|
| Linear Models | 4 | 2019 | 845 | 0.270 |
Why?
|
| Regression Analysis | 9 | 2017 | 1024 | 0.270 |
Why?
|
| Sex Factors | 12 | 2019 | 2068 | 0.270 |
Why?
|
| Prognosis | 9 | 2021 | 4018 | 0.270 |
Why?
|
| Psychology, Child | 1 | 2007 | 38 | 0.270 |
Why?
|
| Environmental Pollutants | 2 | 2024 | 159 | 0.270 |
Why?
|
| Lipid Metabolism | 3 | 2019 | 512 | 0.260 |
Why?
|
| Fetal Distress | 1 | 2006 | 13 | 0.260 |
Why?
|
| Lipase | 3 | 2019 | 68 | 0.260 |
Why?
|
| Bias | 3 | 2021 | 218 | 0.260 |
Why?
|
| Linkage Disequilibrium | 5 | 2011 | 268 | 0.260 |
Why?
|
| Wheat Hypersensitivity | 1 | 2006 | 4 | 0.260 |
Why?
|
| Reproducibility of Results | 10 | 2018 | 3272 | 0.260 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2006 | 33 | 0.250 |
Why?
|
| Abdominal Fat | 6 | 2017 | 41 | 0.250 |
Why?
|
| Heat-Shock Proteins | 1 | 2007 | 142 | 0.250 |
Why?
|
| Insulin Antibodies | 6 | 2016 | 105 | 0.250 |
Why?
|
| Precision Medicine | 2 | 2020 | 426 | 0.250 |
Why?
|
| Immunophenotyping | 2 | 2025 | 319 | 0.250 |
Why?
|
| Immunoglobulin M | 5 | 2022 | 288 | 0.250 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2006 | 77 | 0.250 |
Why?
|
| Vitamin D-Binding Protein | 3 | 2021 | 15 | 0.250 |
Why?
|
| Lipids | 6 | 2025 | 665 | 0.250 |
Why?
|
| C-Peptide | 4 | 2017 | 163 | 0.240 |
Why?
|
| Genetic Markers | 6 | 2013 | 344 | 0.240 |
Why?
|
| Protective Factors | 2 | 2016 | 93 | 0.240 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2021 | 1242 | 0.240 |
Why?
|
| Risk | 8 | 2019 | 904 | 0.240 |
Why?
|
| Autoantigens | 5 | 2021 | 428 | 0.240 |
Why?
|
| Cattle | 7 | 2017 | 981 | 0.240 |
Why?
|
| Electroconvulsive Therapy | 2 | 1996 | 14 | 0.230 |
Why?
|
| Leptospira | 1 | 2025 | 4 | 0.230 |
Why?
|
| Leptospirosis | 1 | 2025 | 8 | 0.230 |
Why?
|
| Birth Weight | 4 | 2018 | 514 | 0.230 |
Why?
|
| Time Factors | 17 | 2017 | 6792 | 0.230 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2006 | 113 | 0.230 |
Why?
|
| beta Carotene | 1 | 2024 | 22 | 0.230 |
Why?
|
| Aged, 80 and over | 18 | 2019 | 7569 | 0.230 |
Why?
|
| Chromosome Mapping | 12 | 2009 | 523 | 0.230 |
Why?
|
| Rubella | 2 | 2023 | 24 | 0.230 |
Why?
|
| Chlamydia trachomatis | 1 | 2025 | 48 | 0.230 |
Why?
|
| Vitamin A | 1 | 2024 | 58 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 17 | 5 | 2008 | 55 | 0.220 |
Why?
|
| Glucose Tolerance Test | 10 | 2018 | 364 | 0.220 |
Why?
|
| Fatty Acids | 2 | 2021 | 444 | 0.220 |
Why?
|
| Sweden | 6 | 2024 | 101 | 0.220 |
Why?
|
| Alanine Transaminase | 3 | 2021 | 157 | 0.220 |
Why?
|
| Germany | 6 | 2024 | 121 | 0.220 |
Why?
|
| Body Composition | 5 | 2017 | 677 | 0.220 |
Why?
|
| Disease Susceptibility | 4 | 2020 | 344 | 0.220 |
Why?
|
| Hypertension | 5 | 2020 | 1284 | 0.220 |
Why?
|
| Chlamydia Infections | 1 | 2025 | 74 | 0.210 |
Why?
|
| Fasting | 7 | 2015 | 278 | 0.210 |
Why?
|
| Bottle Feeding | 2 | 2018 | 21 | 0.210 |
Why?
|
| Vitamin B Complex | 1 | 2024 | 41 | 0.210 |
Why?
|
| Germ-Line Mutation | 1 | 2024 | 172 | 0.210 |
Why?
|
| Mumps | 1 | 2023 | 25 | 0.210 |
Why?
|
| Australia | 5 | 2016 | 314 | 0.210 |
Why?
|
| Arteriosclerosis | 6 | 2005 | 88 | 0.210 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2024 | 137 | 0.210 |
Why?
|
| Data Accuracy | 1 | 2024 | 63 | 0.210 |
Why?
|
| Nerve Tissue Proteins | 3 | 2023 | 596 | 0.210 |
Why?
|
| Nuclear Family | 5 | 2019 | 54 | 0.210 |
Why?
|
| GTPase-Activating Proteins | 1 | 2023 | 82 | 0.210 |
Why?
|
| Measles | 1 | 2023 | 46 | 0.210 |
Why?
|
| Iron Overload | 1 | 2023 | 17 | 0.210 |
Why?
|
| Intestinal Mucosa | 1 | 2008 | 620 | 0.200 |
Why?
|
| Erythrocytes | 2 | 2021 | 692 | 0.200 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2016 | 17 | 0.200 |
Why?
|
| Interleukin-6 | 2 | 2021 | 778 | 0.200 |
Why?
|
| Chickenpox | 1 | 2023 | 83 | 0.200 |
Why?
|
| Protein-Arginine Deiminases | 3 | 2021 | 16 | 0.200 |
Why?
|
| Prevalence | 6 | 2017 | 2712 | 0.200 |
Why?
|
| Mucous Membrane | 2 | 2024 | 125 | 0.190 |
Why?
|
| Finland | 5 | 2024 | 90 | 0.190 |
Why?
|
| Pediatric Obesity | 3 | 2018 | 590 | 0.190 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 2 | 2021 | 63 | 0.190 |
Why?
|
| Citrullination | 2 | 2020 | 13 | 0.190 |
Why?
|
| Urine | 1 | 2002 | 55 | 0.190 |
Why?
|
| Cotinine | 1 | 2002 | 87 | 0.180 |
Why?
|
| Transcription Factors | 3 | 2019 | 1714 | 0.180 |
Why?
|
| Aspartate Aminotransferases | 2 | 2019 | 90 | 0.180 |
Why?
|
| Citrulline | 2 | 2016 | 45 | 0.180 |
Why?
|
| Sulfates | 1 | 2021 | 50 | 0.180 |
Why?
|
| Bacteroides Infections | 1 | 2001 | 2 | 0.180 |
Why?
|
| Propensity Score | 1 | 2023 | 288 | 0.180 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2021 | 43 | 0.180 |
Why?
|
| Liver Glycogen | 1 | 2021 | 17 | 0.180 |
Why?
|
| Lactones | 1 | 2021 | 56 | 0.180 |
Why?
|
| Apolipoproteins E | 1 | 2021 | 83 | 0.180 |
Why?
|
| Linoleic Acid | 1 | 2021 | 43 | 0.180 |
Why?
|
| Sunlight | 1 | 2001 | 73 | 0.180 |
Why?
|
| Arthralgia | 1 | 2021 | 55 | 0.180 |
Why?
|
| Protein Phosphatase 1 | 1 | 2021 | 33 | 0.170 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2021 | 532 | 0.170 |
Why?
|
| Lod Score | 7 | 2017 | 67 | 0.170 |
Why?
|
| Glycogen Storage Disease | 1 | 2021 | 19 | 0.170 |
Why?
|
| Lymphocyte Activation | 1 | 2025 | 1150 | 0.170 |
Why?
|
| Health Status | 2 | 2023 | 781 | 0.170 |
Why?
|
| Fluoroquinolones | 2 | 2011 | 50 | 0.170 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2025 | 913 | 0.170 |
Why?
|
| Iodide Peroxidase | 1 | 2020 | 28 | 0.170 |
Why?
|
| Antibodies, Viral | 3 | 2019 | 622 | 0.170 |
Why?
|
| Specimen Handling | 1 | 2002 | 178 | 0.170 |
Why?
|
| Registries | 9 | 2019 | 2015 | 0.170 |
Why?
|
| Origin of Life | 1 | 2020 | 8 | 0.170 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2020 | 8 | 0.170 |
Why?
|
| Isotopes | 1 | 2020 | 33 | 0.170 |
Why?
|
| Fatty Liver | 3 | 2013 | 242 | 0.170 |
Why?
|
| Prediabetic State | 3 | 2012 | 253 | 0.170 |
Why?
|
| Father-Child Relations | 1 | 2019 | 6 | 0.160 |
Why?
|
| Interleukin-8 | 1 | 2021 | 267 | 0.160 |
Why?
|
| Gastroenteritis | 2 | 2019 | 68 | 0.160 |
Why?
|
| Peroxidase | 1 | 2020 | 176 | 0.160 |
Why?
|
| Mental Recall | 4 | 2017 | 201 | 0.160 |
Why?
|
| Toll-Like Receptors | 1 | 2020 | 185 | 0.160 |
Why?
|
| Survival Analysis | 4 | 2017 | 1319 | 0.160 |
Why?
|
| Endopeptidases | 1 | 2000 | 90 | 0.160 |
Why?
|
| Dogs | 6 | 2025 | 409 | 0.160 |
Why?
|
| Metabolic Clearance Rate | 3 | 2014 | 116 | 0.160 |
Why?
|
| Mycobacterium | 2 | 2011 | 109 | 0.160 |
Why?
|
| Endocrinology | 1 | 2020 | 79 | 0.160 |
Why?
|
| Self Report | 2 | 2022 | 825 | 0.160 |
Why?
|
| Iron | 2 | 2023 | 311 | 0.160 |
Why?
|
| Threonine | 1 | 1999 | 46 | 0.160 |
Why?
|
| Antigens, Viral | 2 | 2019 | 180 | 0.160 |
Why?
|
| Gingiva | 1 | 1999 | 25 | 0.160 |
Why?
|
| Parents | 2 | 2007 | 1355 | 0.150 |
Why?
|
| HLA-D Antigens | 2 | 2017 | 34 | 0.150 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 2 | 2017 | 23 | 0.150 |
Why?
|
| Interleukin-1beta | 1 | 2021 | 372 | 0.150 |
Why?
|
| Meta-Analysis as Topic | 1 | 2019 | 172 | 0.150 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1999 | 132 | 0.150 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2021 | 591 | 0.150 |
Why?
|
| Health | 2 | 2013 | 84 | 0.150 |
Why?
|
| Subcutaneous Fat | 5 | 2010 | 81 | 0.150 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2024 | 556 | 0.150 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2012 | 86 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2025 | 1092 | 0.150 |
Why?
|
| Histones | 2 | 2021 | 635 | 0.150 |
Why?
|
| Antibodies | 3 | 2011 | 412 | 0.150 |
Why?
|
| Arthritis, Experimental | 1 | 2020 | 147 | 0.150 |
Why?
|
| Herpesvirus 4, Human | 1 | 2019 | 167 | 0.150 |
Why?
|
| Collagen | 2 | 2020 | 445 | 0.150 |
Why?
|
| Interleukins | 1 | 2020 | 251 | 0.140 |
Why?
|
| Hypersensitivity | 1 | 2021 | 257 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2013 | 429 | 0.140 |
Why?
|
| Leadership | 1 | 2022 | 380 | 0.140 |
Why?
|
| Herpesviridae Infections | 1 | 2019 | 148 | 0.140 |
Why?
|
| Emergency Nursing | 1 | 2017 | 22 | 0.140 |
Why?
|
| Child Health | 1 | 2019 | 156 | 0.140 |
Why?
|
| Gestational Age | 4 | 2020 | 902 | 0.140 |
Why?
|
| Monocytes | 1 | 2020 | 561 | 0.140 |
Why?
|
| Sensitivity and Specificity | 5 | 2015 | 1942 | 0.140 |
Why?
|
| Allied Health Personnel | 1 | 2017 | 45 | 0.140 |
Why?
|
| Chromatography, Liquid | 1 | 2019 | 432 | 0.140 |
Why?
|
| Patient Handoff | 1 | 2017 | 33 | 0.140 |
Why?
|
| Niacin | 1 | 2017 | 17 | 0.140 |
Why?
|
| Maternal Age | 3 | 2004 | 129 | 0.140 |
Why?
|
| Enterovirus Infections | 3 | 2010 | 177 | 0.140 |
Why?
|
| Socioeconomic Factors | 6 | 2017 | 1281 | 0.130 |
Why?
|
| Bone Density | 1 | 2021 | 487 | 0.130 |
Why?
|
| Consensus | 1 | 2020 | 679 | 0.130 |
Why?
|
| Patient Care Team | 1 | 2022 | 627 | 0.130 |
Why?
|
| Pipecolic Acids | 1 | 1997 | 26 | 0.130 |
Why?
|
| Bacterial Proteins | 2 | 2001 | 895 | 0.130 |
Why?
|
| Mothers | 4 | 2018 | 752 | 0.130 |
Why?
|
| Calcium | 1 | 2023 | 1197 | 0.130 |
Why?
|
| NFI Transcription Factors | 1 | 2016 | 8 | 0.130 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2013 | 39 | 0.130 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 432 | 0.130 |
Why?
|
| Oxidative Stress | 1 | 2003 | 1309 | 0.130 |
Why?
|
| Myocardial Infarction | 2 | 2021 | 1045 | 0.130 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 1997 | 100 | 0.130 |
Why?
|
| Amino Acid Sequence | 7 | 2000 | 2145 | 0.130 |
Why?
|
| Algorithms | 2 | 2023 | 1686 | 0.130 |
Why?
|
| Laminin | 1 | 2016 | 72 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2022 | 826 | 0.130 |
Why?
|
| Research | 1 | 2019 | 445 | 0.130 |
Why?
|
| Plasma Cells | 1 | 2016 | 71 | 0.130 |
Why?
|
| Prenatal Care | 2 | 2017 | 287 | 0.130 |
Why?
|
| Hydrolases | 2 | 2021 | 56 | 0.130 |
Why?
|
| Coxiella burnetii | 1 | 2016 | 2 | 0.130 |
Why?
|
| Q Fever | 1 | 2016 | 5 | 0.130 |
Why?
|
| Respiratory Tract Infections | 2 | 2019 | 396 | 0.130 |
Why?
|
| Factor Analysis, Statistical | 1 | 2017 | 286 | 0.130 |
Why?
|
| Retrospective Studies | 13 | 2022 | 15564 | 0.130 |
Why?
|
| Adipogenesis | 1 | 2016 | 54 | 0.120 |
Why?
|
| Prolactin | 1 | 1996 | 97 | 0.120 |
Why?
|
| Databases, Factual | 3 | 2018 | 1347 | 0.120 |
Why?
|
| Complement System Proteins | 1 | 2019 | 327 | 0.120 |
Why?
|
| Cerebrovascular Disorders | 1 | 1997 | 96 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2017 | 2677 | 0.120 |
Why?
|
| Umbilical Cord | 1 | 2016 | 85 | 0.120 |
Why?
|
| Fatigue | 1 | 2018 | 327 | 0.120 |
Why?
|
| Diet, High-Fat | 1 | 2017 | 247 | 0.120 |
Why?
|
| Niacinamide | 1 | 2016 | 78 | 0.120 |
Why?
|
| Microsatellite Repeats | 2 | 2014 | 167 | 0.120 |
Why?
|
| Haplotypes | 6 | 2008 | 490 | 0.120 |
Why?
|
| Arthritis | 1 | 2016 | 95 | 0.120 |
Why?
|
| Patient Transfer | 1 | 2017 | 165 | 0.120 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2015 | 60 | 0.120 |
Why?
|
| Environment | 3 | 2019 | 362 | 0.120 |
Why?
|
| Cardiovascular Diseases | 4 | 2021 | 2108 | 0.120 |
Why?
|
| Dietary Fiber | 1 | 2015 | 53 | 0.120 |
Why?
|
| Predictive Value of Tests | 9 | 2018 | 2030 | 0.120 |
Why?
|
| Early Diagnosis | 4 | 2019 | 243 | 0.120 |
Why?
|
| Interleukin-2 | 2 | 2016 | 454 | 0.120 |
Why?
|
| Mutation Rate | 1 | 2015 | 29 | 0.120 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2014 | 23 | 0.120 |
Why?
|
| Quality of Life | 3 | 2024 | 2868 | 0.120 |
Why?
|
| Self Disclosure | 2 | 2007 | 63 | 0.110 |
Why?
|
| Metabolome | 1 | 2018 | 350 | 0.110 |
Why?
|
| Gene-Environment Interaction | 4 | 2018 | 194 | 0.110 |
Why?
|
| Minority Groups | 3 | 2011 | 267 | 0.110 |
Why?
|
| Pesticides | 1 | 2014 | 61 | 0.110 |
Why?
|
| Serum Albumin, Bovine | 1 | 1994 | 64 | 0.110 |
Why?
|
| Beverages | 1 | 2014 | 69 | 0.110 |
Why?
|
| Selenoprotein P | 1 | 2013 | 3 | 0.110 |
Why?
|
| Siblings | 3 | 2010 | 228 | 0.110 |
Why?
|
| Liver | 7 | 2023 | 1938 | 0.110 |
Why?
|
| Mental Health | 1 | 2020 | 721 | 0.110 |
Why?
|
| Dominance, Cerebral | 1 | 1993 | 54 | 0.110 |
Why?
|
| Body Weight | 3 | 2017 | 981 | 0.110 |
Why?
|
| Models, Nursing | 1 | 2013 | 37 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2023 | 455 | 0.100 |
Why?
|
| Schizophrenic Psychology | 1 | 1993 | 94 | 0.100 |
Why?
|
| Geographic Information Systems | 1 | 2013 | 43 | 0.100 |
Why?
|
| Immunoglobulins | 2 | 2015 | 171 | 0.100 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 2831 | 0.100 |
Why?
|
| Interleukin-9 | 1 | 2012 | 9 | 0.100 |
Why?
|
| Genes, MHC Class II | 1 | 2012 | 74 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 3 | 3 | 2010 | 50 | 0.100 |
Why?
|
| Tuberculosis, Bovine | 1 | 2012 | 4 | 0.100 |
Why?
|
| Cell Membrane | 1 | 2016 | 736 | 0.100 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 183 | 0.100 |
Why?
|
| Asthma | 2 | 2023 | 2290 | 0.100 |
Why?
|
| Likelihood Functions | 4 | 2012 | 142 | 0.100 |
Why?
|
| Molecular Sequence Data | 6 | 2000 | 2903 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1568 | 0.100 |
Why?
|
| Epistasis, Genetic | 3 | 2020 | 71 | 0.100 |
Why?
|
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 3 | 2023 | 26 | 0.100 |
Why?
|
| Patient Compliance | 2 | 2015 | 576 | 0.090 |
Why?
|
| Whole Genome Sequencing | 2 | 2024 | 152 | 0.090 |
Why?
|
| Bronchial Diseases | 1 | 2011 | 37 | 0.090 |
Why?
|
| Child of Impaired Parents | 1 | 2012 | 41 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 1997 | 1043 | 0.090 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2011 | 7 | 0.090 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 152 | 0.090 |
Why?
|
| Body Fat Distribution | 2 | 2013 | 49 | 0.090 |
Why?
|
| HLA-DRB1 Chains | 3 | 2012 | 112 | 0.090 |
Why?
|
| Nocardia | 1 | 2011 | 2 | 0.090 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2012 | 159 | 0.090 |
Why?
|
| Nocardia Infections | 1 | 2011 | 9 | 0.090 |
Why?
|
| Histocompatibility Testing | 3 | 2007 | 126 | 0.090 |
Why?
|
| Vegetables | 2 | 2013 | 155 | 0.090 |
Why?
|
| Alcohol Drinking | 1 | 2018 | 818 | 0.090 |
Why?
|
| DNA Primers | 4 | 2007 | 513 | 0.090 |
Why?
|
| Insurance, Health | 3 | 1999 | 278 | 0.090 |
Why?
|
| Mycobacterium Infections | 1 | 2011 | 63 | 0.090 |
Why?
|
| Electroencephalography | 1 | 1993 | 433 | 0.090 |
Why?
|
| Triticum | 1 | 2010 | 17 | 0.090 |
Why?
|
| Bipolar Disorder | 1 | 1993 | 264 | 0.090 |
Why?
|
| Mice | 6 | 2022 | 17731 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 532 | 0.090 |
Why?
|
| Societies, Medical | 3 | 2020 | 820 | 0.090 |
Why?
|
| DNA Mutational Analysis | 3 | 2024 | 400 | 0.090 |
Why?
|
| Particulate Matter | 1 | 2013 | 312 | 0.080 |
Why?
|
| DNA | 4 | 2009 | 1458 | 0.080 |
Why?
|
| Environmental Monitoring | 1 | 2013 | 369 | 0.080 |
Why?
|
| Diet, Gluten-Free | 2 | 2024 | 45 | 0.080 |
Why?
|
| Depressive Disorder | 1 | 1993 | 380 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 1994 | 707 | 0.080 |
Why?
|
| Plant Proteins | 1 | 2011 | 114 | 0.080 |
Why?
|
| Qualitative Research | 1 | 2017 | 1359 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2001 | 345 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2010 | 430 | 0.080 |
Why?
|
| Decision Making | 1 | 2017 | 896 | 0.080 |
Why?
|
| Health Fairs | 1 | 2009 | 9 | 0.080 |
Why?
|
| Liver Cirrhosis | 2 | 2023 | 316 | 0.080 |
Why?
|
| Synovitis | 1 | 2009 | 27 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2004 | 72 | 0.080 |
Why?
|
| Gliadin | 1 | 2009 | 13 | 0.080 |
Why?
|
| Cholera Toxin | 1 | 2009 | 32 | 0.080 |
Why?
|
| Fetal Weight | 1 | 2009 | 56 | 0.080 |
Why?
|
| Biopsy | 3 | 2015 | 1126 | 0.080 |
Why?
|
| Schizophrenia | 1 | 1993 | 439 | 0.080 |
Why?
|
| Receptors, Somatostatin | 1 | 2009 | 25 | 0.080 |
Why?
|
| I-kappa B Proteins | 1 | 2009 | 81 | 0.080 |
Why?
|
| Nutrition Surveys | 3 | 2014 | 267 | 0.080 |
Why?
|
| Haptoglobins | 1 | 2009 | 53 | 0.080 |
Why?
|
| Intestinal Absorption | 1 | 2009 | 101 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2013 | 418 | 0.080 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 21 | 0.080 |
Why?
|
| Interferon-gamma | 1 | 2012 | 790 | 0.080 |
Why?
|
| Depression | 1 | 2018 | 1402 | 0.080 |
Why?
|
| Milk, Human | 1 | 2010 | 158 | 0.080 |
Why?
|
| Immunization | 2 | 2022 | 410 | 0.080 |
Why?
|
| Nutrition Assessment | 3 | 2017 | 90 | 0.070 |
Why?
|
| Protein Precursors | 1 | 2009 | 132 | 0.070 |
Why?
|
| Rheumatology | 1 | 2010 | 120 | 0.070 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2008 | 7 | 0.070 |
Why?
|
| Antigens, CD | 2 | 2009 | 522 | 0.070 |
Why?
|
| Seasons | 4 | 2019 | 544 | 0.070 |
Why?
|
| Permeability | 1 | 2008 | 162 | 0.070 |
Why?
|
| Antirheumatic Agents | 2 | 2015 | 290 | 0.070 |
Why?
|
| Solanum tuberosum | 1 | 2008 | 7 | 0.070 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2021 | 114 | 0.070 |
Why?
|
| Gastrointestinal Tract | 1 | 2010 | 193 | 0.070 |
Why?
|
| Organ Specificity | 2 | 2019 | 304 | 0.070 |
Why?
|
| TCF Transcription Factors | 1 | 2007 | 17 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2001 | 1225 | 0.070 |
Why?
|
| Influenza Vaccines | 1 | 2012 | 539 | 0.070 |
Why?
|
| Aging | 3 | 2016 | 1861 | 0.070 |
Why?
|
| HLA-DP Antigens | 1 | 2007 | 33 | 0.070 |
Why?
|
| gamma-Glutamyltransferase | 2 | 2019 | 43 | 0.070 |
Why?
|
| Creatinine | 2 | 2006 | 498 | 0.070 |
Why?
|
| Seafood | 1 | 2007 | 27 | 0.070 |
Why?
|
| Hypoglycemic Agents | 2 | 2015 | 1281 | 0.070 |
Why?
|
| Genotyping Techniques | 2 | 2017 | 75 | 0.070 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2007 | 43 | 0.070 |
Why?
|
| Carotenoids | 1 | 2007 | 43 | 0.070 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2009 | 202 | 0.070 |
Why?
|
| Rotavirus | 1 | 2006 | 20 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2020 | 386 | 0.070 |
Why?
|
| Plethysmography | 2 | 2017 | 106 | 0.070 |
Why?
|
| Proteins | 2 | 2011 | 1009 | 0.060 |
Why?
|
| Influenza, Human | 1 | 2012 | 624 | 0.060 |
Why?
|
| Rotavirus Infections | 1 | 2006 | 43 | 0.060 |
Why?
|
| Artificial Intelligence | 1 | 2010 | 272 | 0.060 |
Why?
|
| Glucose Intolerance | 2 | 2008 | 146 | 0.060 |
Why?
|
| Delivery, Obstetric | 2 | 2004 | 145 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2006 | 59 | 0.060 |
Why?
|
| Cholesterol, LDL | 2 | 2019 | 366 | 0.060 |
Why?
|
| Health Behavior | 1 | 2012 | 756 | 0.060 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 309 | 0.060 |
Why?
|
| Weight Gain | 1 | 2009 | 518 | 0.060 |
Why?
|
| Mutation | 1 | 2017 | 3953 | 0.060 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2005 | 18 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 4 | 2016 | 1059 | 0.060 |
Why?
|
| Fibrinogen | 2 | 2019 | 168 | 0.060 |
Why?
|
| Trypsin Inhibitor, Kazal Pancreatic | 1 | 2005 | 6 | 0.060 |
Why?
|
| Gene Expression Regulation | 3 | 2016 | 2603 | 0.060 |
Why?
|
| Genome Components | 1 | 2005 | 2 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2005 | 45 | 0.060 |
Why?
|
| New South Wales | 1 | 2025 | 19 | 0.060 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2025 | 50 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2011 | 768 | 0.060 |
Why?
|
| Paternal Age | 1 | 2024 | 3 | 0.060 |
Why?
|
| Antibodies, Antinuclear | 2 | 2014 | 71 | 0.060 |
Why?
|
| Switzerland | 1 | 2025 | 37 | 0.060 |
Why?
|
| Codon | 1 | 2005 | 89 | 0.060 |
Why?
|
| gamma-Tocopherol | 1 | 2024 | 8 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2017 | 891 | 0.060 |
Why?
|
| alpha-Tocopherol | 1 | 2024 | 33 | 0.060 |
Why?
|
| Postpartum Period | 2 | 2021 | 336 | 0.060 |
Why?
|
| Arthritis, Juvenile | 1 | 2005 | 56 | 0.060 |
Why?
|
| Receptors, CXCR5 | 1 | 2024 | 21 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 2 | 2019 | 209 | 0.050 |
Why?
|
| Albuminuria | 1 | 2005 | 185 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2005 | 154 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 3 | 2004 | 47 | 0.050 |
Why?
|
| Phospholipases | 1 | 2023 | 14 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 96 | 0.050 |
Why?
|
| Radiography | 3 | 2013 | 829 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 2 | 2017 | 811 | 0.050 |
Why?
|
| Acyltransferases | 1 | 2023 | 56 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 379 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 2 | 2011 | 1799 | 0.050 |
Why?
|
| Pulmonary Fibrosis | 1 | 2007 | 400 | 0.050 |
Why?
|
| Iron, Dietary | 1 | 2023 | 21 | 0.050 |
Why?
|
| Reference Values | 3 | 1999 | 817 | 0.050 |
Why?
|
| Glutamates | 1 | 2023 | 59 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 2022 | 480 | 0.050 |
Why?
|
| Urban Health | 2 | 2006 | 92 | 0.050 |
Why?
|
| Abdomen | 1 | 2003 | 125 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 3 | 2004 | 171 | 0.050 |
Why?
|
| Income | 1 | 2003 | 200 | 0.050 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2022 | 34 | 0.050 |
Why?
|
| Nitrates | 1 | 1992 | 92 | 0.050 |
Why?
|
| Water Supply | 1 | 1992 | 78 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2000 | 387 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2004 | 10764 | 0.050 |
Why?
|
| Occult Blood | 1 | 2001 | 34 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2021 | 20 | 0.050 |
Why?
|
| Epidemiologic Studies | 1 | 2021 | 72 | 0.050 |
Why?
|
| Selection Bias | 1 | 2021 | 37 | 0.050 |
Why?
|
| Rats | 5 | 2025 | 5628 | 0.040 |
Why?
|
| Diagnostic Techniques, Radioisotope | 1 | 2021 | 9 | 0.040 |
Why?
|
| Immunization Schedule | 1 | 2022 | 197 | 0.040 |
Why?
|
| Immunoglobulin D | 1 | 2021 | 30 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2021 | 54 | 0.040 |
Why?
|
| Fimbriae, Bacterial | 1 | 2001 | 32 | 0.040 |
Why?
|
| Pseudomonas Infections | 1 | 2003 | 224 | 0.040 |
Why?
|
| Ciprofloxacin | 2 | 2011 | 29 | 0.040 |
Why?
|
| Waist Circumference | 2 | 2013 | 143 | 0.040 |
Why?
|
| Electrochemical Techniques | 1 | 2021 | 51 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 1031 | 0.040 |
Why?
|
| Probability | 1 | 2021 | 309 | 0.040 |
Why?
|
| Financial Management | 1 | 2020 | 17 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 1 | 2006 | 565 | 0.040 |
Why?
|
| Asymptomatic Diseases | 1 | 2021 | 87 | 0.040 |
Why?
|
| Sequence Analysis, Protein | 1 | 2000 | 31 | 0.040 |
Why?
|
| Synovial Fluid | 1 | 2020 | 69 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2022 | 302 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2024 | 1181 | 0.040 |
Why?
|
| Databases, Genetic | 1 | 2021 | 236 | 0.040 |
Why?
|
| Collagenases | 1 | 2000 | 25 | 0.040 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2019 | 12 | 0.040 |
Why?
|
| Mannose | 1 | 2019 | 24 | 0.040 |
Why?
|
| Laryngitis | 1 | 2019 | 4 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 174 | 0.040 |
Why?
|
| Adenosine Diphosphate | 1 | 2019 | 79 | 0.040 |
Why?
|
| Norway | 1 | 2019 | 44 | 0.040 |
Why?
|
| Sequence Homology | 1 | 1999 | 40 | 0.040 |
Why?
|
| Gene Library | 1 | 2000 | 117 | 0.040 |
Why?
|
| Immunoglobulin Variable Region | 2 | 1996 | 80 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2011 | 356 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2000 | 345 | 0.040 |
Why?
|
| Periodontal Index | 1 | 1999 | 13 | 0.040 |
Why?
|
| Conjunctivitis | 1 | 2019 | 30 | 0.040 |
Why?
|
| Cuspid | 1 | 1999 | 11 | 0.040 |
Why?
|
| Bicuspid | 1 | 1999 | 17 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 1999 | 72 | 0.040 |
Why?
|
| DNA Probes | 1 | 1999 | 60 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2003 | 389 | 0.040 |
Why?
|
| Residence Characteristics | 2 | 2019 | 354 | 0.040 |
Why?
|
| Health Plan Implementation | 1 | 2020 | 137 | 0.040 |
Why?
|
| Maternal Behavior | 1 | 1999 | 77 | 0.040 |
Why?
|
| Butyrates | 1 | 2019 | 61 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 1996 | 1428 | 0.040 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2019 | 14 | 0.040 |
Why?
|
| Energy Metabolism | 2 | 2018 | 918 | 0.040 |
Why?
|
| Immunoglobulin E | 1 | 2021 | 341 | 0.040 |
Why?
|
| Colony Count, Microbial | 1 | 1999 | 120 | 0.040 |
Why?
|
| Methotrexate | 1 | 2020 | 260 | 0.040 |
Why?
|
| Lung | 3 | 2017 | 4065 | 0.040 |
Why?
|
| Calibration | 1 | 1999 | 145 | 0.040 |
Why?
|
| Epidemiologic Methods | 2 | 2013 | 96 | 0.040 |
Why?
|
| Reference Standards | 1 | 1999 | 183 | 0.040 |
Why?
|
| Brazil | 1 | 2019 | 167 | 0.040 |
Why?
|
| Health Equity | 1 | 2020 | 99 | 0.040 |
Why?
|
| Health Services | 1 | 1999 | 103 | 0.040 |
Why?
|
| Powders | 1 | 2018 | 43 | 0.040 |
Why?
|
| Outpatients | 1 | 1992 | 393 | 0.040 |
Why?
|
| Proteomics | 1 | 2025 | 1108 | 0.040 |
Why?
|
| Small-Area Analysis | 1 | 1997 | 7 | 0.040 |
Why?
|
| Abortion, Spontaneous | 1 | 1999 | 105 | 0.040 |
Why?
|
| Fever | 1 | 2019 | 307 | 0.040 |
Why?
|
| Tobacco Products | 1 | 2019 | 142 | 0.040 |
Why?
|
| Community Health Planning | 1 | 1997 | 42 | 0.030 |
Why?
|
| Multiple Organ Failure | 1 | 1998 | 127 | 0.030 |
Why?
|
| Multiple Trauma | 1 | 1998 | 101 | 0.030 |
Why?
|
| Forecasting | 1 | 2019 | 384 | 0.030 |
Why?
|
| Diastole | 1 | 2018 | 150 | 0.030 |
Why?
|
| Whooping Cough | 1 | 1997 | 51 | 0.030 |
Why?
|
| Discriminant Analysis | 1 | 2017 | 37 | 0.030 |
Why?
|
| Abdominal Neoplasms | 1 | 1977 | 39 | 0.030 |
Why?
|
| Systole | 1 | 2018 | 191 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2019 | 195 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2019 | 218 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 1999 | 336 | 0.030 |
Why?
|
| Health Planning | 1 | 1997 | 47 | 0.030 |
Why?
|
| Muscle Proteins | 1 | 2019 | 229 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2004 | 1981 | 0.030 |
Why?
|
| Hospitalization | 2 | 2004 | 2195 | 0.030 |
Why?
|
| Blood Group Antigens | 1 | 1997 | 15 | 0.030 |
Why?
|
| Otitis Media | 1 | 2019 | 165 | 0.030 |
Why?
|
| Titanium | 1 | 1977 | 82 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2017 | 334 | 0.030 |
Why?
|
| Genes, Immunoglobulin Light Chain | 1 | 2016 | 4 | 0.030 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2016 | 9 | 0.030 |
Why?
|
| Phosphofructokinase-2 | 1 | 2016 | 15 | 0.030 |
Why?
|
| Cholesterol | 1 | 2019 | 410 | 0.030 |
Why?
|
| CTLA-4 Antigen | 2 | 2009 | 99 | 0.030 |
Why?
|
| Glomerular Mesangium | 1 | 1996 | 21 | 0.030 |
Why?
|
| Diabetes Complications | 1 | 2018 | 226 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1997 | 128 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 66 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2002 | 1697 | 0.030 |
Why?
|
| Acute Disease | 1 | 2019 | 1006 | 0.030 |
Why?
|
| Antibody Formation | 1 | 2018 | 298 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2017 | 77 | 0.030 |
Why?
|
| Data Collection | 1 | 2019 | 664 | 0.030 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 30 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2000 | 1354 | 0.030 |
Why?
|
| Models, Biological | 2 | 2019 | 1769 | 0.030 |
Why?
|
| Los Angeles | 2 | 2008 | 76 | 0.030 |
Why?
|
| Enterovirus | 1 | 1997 | 86 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 738 | 0.030 |
Why?
|
| Complement Activation | 1 | 2019 | 411 | 0.030 |
Why?
|
| Electrodes | 1 | 1996 | 113 | 0.030 |
Why?
|
| Fragile X Syndrome | 1 | 1996 | 77 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 400 | 0.030 |
Why?
|
| Infant Mortality | 1 | 1996 | 115 | 0.030 |
Why?
|
| Bromobenzenes | 1 | 1975 | 1 | 0.030 |
Why?
|
| Phenyl Ethers | 1 | 1975 | 4 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 687 | 0.030 |
Why?
|
| Mortality | 2 | 2007 | 357 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 1997 | 200 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2000 | 812 | 0.030 |
Why?
|
| Georgia | 1 | 2015 | 84 | 0.030 |
Why?
|
| Functional Laterality | 1 | 1996 | 223 | 0.030 |
Why?
|
| Symptom Assessment | 1 | 2016 | 125 | 0.030 |
Why?
|
| Florida | 1 | 2015 | 101 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2021 | 557 | 0.030 |
Why?
|
| Patient-Centered Care | 1 | 2020 | 520 | 0.030 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2015 | 33 | 0.030 |
Why?
|
| Erythrocyte Count | 1 | 2014 | 19 | 0.030 |
Why?
|
| Blood Proteins | 1 | 1997 | 249 | 0.030 |
Why?
|
| Washington | 1 | 2015 | 154 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 1975 | 63 | 0.030 |
Why?
|
| North America | 1 | 1996 | 313 | 0.030 |
Why?
|
| Databases, Nucleic Acid | 1 | 2014 | 34 | 0.030 |
Why?
|
| Solubility | 1 | 2015 | 247 | 0.030 |
Why?
|
| Hematocrit | 1 | 2014 | 95 | 0.030 |
Why?
|
| Base Sequence | 3 | 2010 | 2180 | 0.030 |
Why?
|
| Neurology | 1 | 1996 | 114 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 2015 | 117 | 0.030 |
Why?
|
| Rituximab | 1 | 2015 | 178 | 0.030 |
Why?
|
| Cross-Cultural Comparison | 1 | 2015 | 90 | 0.030 |
Why?
|
| Isoenzymes | 2 | 2006 | 304 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 2045 | 0.030 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2015 | 82 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2014 | 119 | 0.030 |
Why?
|
| Patient Safety | 1 | 2017 | 304 | 0.030 |
Why?
|
| Cholesterol Ester Transfer Proteins | 1 | 2014 | 20 | 0.030 |
Why?
|
| Apolipoproteins | 1 | 2014 | 33 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2014 | 330 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1768 | 0.030 |
Why?
|
| Lipoproteins, HDL | 1 | 2014 | 77 | 0.030 |
Why?
|
| Birth Order | 2 | 2004 | 14 | 0.030 |
Why?
|
| Neurocan | 1 | 2013 | 1 | 0.030 |
Why?
|
| Family Characteristics | 1 | 2015 | 188 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2020 | 689 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2001 | 792 | 0.030 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2013 | 10 | 0.030 |
Why?
|
| Lysophospholipase | 1 | 2013 | 10 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2008 | 368 | 0.030 |
Why?
|
| Plant Roots | 1 | 2013 | 45 | 0.030 |
Why?
|
| Glucose Clamp Technique | 1 | 2014 | 194 | 0.030 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2013 | 36 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2013 | 67 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2013 | 67 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 1996 | 265 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 1997 | 341 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 2003 | 1104 | 0.030 |
Why?
|
| HLA-DR2 Antigen | 1 | 2012 | 7 | 0.030 |
Why?
|
| Fetal Development | 1 | 2016 | 296 | 0.020 |
Why?
|
| Attitude to Health | 1 | 1996 | 439 | 0.020 |
Why?
|
| Culture | 1 | 2013 | 127 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 535 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2009 | 1250 | 0.020 |
Why?
|
| Fruit | 1 | 2013 | 138 | 0.020 |
Why?
|
| Vaccines, Inactivated | 1 | 2012 | 68 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 1993 | 126 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2012 | 82 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 1993 | 150 | 0.020 |
Why?
|
| Ireland | 1 | 2012 | 30 | 0.020 |
Why?
|
| Health Surveys | 2 | 2010 | 517 | 0.020 |
Why?
|
| Genome | 1 | 2014 | 291 | 0.020 |
Why?
|
| Antigens | 1 | 1994 | 358 | 0.020 |
Why?
|
| Intestines | 1 | 2015 | 359 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2014 | 353 | 0.020 |
Why?
|
| Public Health | 1 | 2017 | 576 | 0.020 |
Why?
|
| Tuberculin Test | 1 | 2012 | 36 | 0.020 |
Why?
|
| Models, Statistical | 2 | 2009 | 658 | 0.020 |
Why?
|
| Sentinel Surveillance | 1 | 2012 | 47 | 0.020 |
Why?
|
| Arthrography | 1 | 2011 | 17 | 0.020 |
Why?
|
| Solvents | 1 | 2012 | 110 | 0.020 |
Why?
|
| Communication | 1 | 2017 | 869 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 1994 | 497 | 0.020 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2011 | 19 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 545 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 1294 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2015 | 947 | 0.020 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2011 | 41 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2011 | 70 | 0.020 |
Why?
|
| Silicon Dioxide | 1 | 2012 | 116 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 1994 | 374 | 0.020 |
Why?
|
| Dyslipidemias | 1 | 2013 | 176 | 0.020 |
Why?
|
| Leptin | 1 | 2012 | 234 | 0.020 |
Why?
|
| Indians, North American | 1 | 1997 | 625 | 0.020 |
Why?
|
| Congresses as Topic | 1 | 2012 | 233 | 0.020 |
Why?
|
| Child Abuse | 1 | 1996 | 546 | 0.020 |
Why?
|
| Aza Compounds | 1 | 2010 | 14 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 2012 | 258 | 0.020 |
Why?
|
| Women's Health | 1 | 2013 | 369 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2009 | 54 | 0.020 |
Why?
|
| Obesity, Abdominal | 1 | 2010 | 48 | 0.020 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2015 | 638 | 0.020 |
Why?
|
| Sample Size | 1 | 2010 | 117 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2012 | 389 | 0.020 |
Why?
|
| Space-Time Clustering | 1 | 1989 | 3 | 0.020 |
Why?
|
| Actuarial Analysis | 1 | 1989 | 27 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 1996 | 752 | 0.020 |
Why?
|
| Diarrhea | 1 | 2010 | 183 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2009 | 29 | 0.020 |
Why?
|
| Community-Institutional Relations | 1 | 2009 | 98 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2008 | 9 | 0.020 |
Why?
|
| Quinolines | 1 | 2010 | 177 | 0.020 |
Why?
|
| Southwestern United States | 1 | 2009 | 90 | 0.020 |
Why?
|
| Body Weights and Measures | 1 | 2008 | 36 | 0.020 |
Why?
|
| Disease | 1 | 2010 | 98 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2011 | 188 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 1996 | 976 | 0.020 |
Why?
|
| Genetic Carrier Screening | 1 | 2008 | 28 | 0.020 |
Why?
|
| Medical Records | 2 | 1999 | 172 | 0.020 |
Why?
|
| Coxsackievirus Infections | 1 | 1987 | 14 | 0.020 |
Why?
|
| Sleep Deprivation | 1 | 2010 | 174 | 0.020 |
Why?
|
| Genetic Counseling | 2 | 1999 | 76 | 0.020 |
Why?
|
| Survival | 1 | 2007 | 38 | 0.020 |
Why?
|
| Age Distribution | 2 | 1999 | 391 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2008 | 376 | 0.020 |
Why?
|
| HLA-DP beta-Chains | 1 | 2007 | 86 | 0.020 |
Why?
|
| Spleen | 1 | 2009 | 513 | 0.020 |
Why?
|
| Cause of Death | 1 | 1989 | 429 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2010 | 651 | 0.020 |
Why?
|
| Recurrence | 1 | 2010 | 1058 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2006 | 54 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 5744 | 0.020 |
Why?
|
| Breeding | 1 | 2006 | 62 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 2050 | 0.020 |
Why?
|
| Urban Population | 1 | 2009 | 472 | 0.020 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2005 | 13 | 0.020 |
Why?
|
| Rural Health | 1 | 2006 | 79 | 0.020 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2005 | 16 | 0.020 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 83 | 0.010 |
Why?
|
| Gene Expression | 1 | 2010 | 1499 | 0.010 |
Why?
|
| Rural Population | 1 | 2009 | 561 | 0.010 |
Why?
|
| Albumins | 1 | 2005 | 113 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2005 | 119 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2005 | 217 | 0.010 |
Why?
|
| Interleukin-13 | 1 | 2005 | 149 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 2005 | 145 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2004 | 114 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2003 | 15 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2008 | 572 | 0.010 |
Why?
|
| Pancreatitis | 1 | 2005 | 132 | 0.010 |
Why?
|
| Motor Activity | 1 | 2009 | 719 | 0.010 |
Why?
|
| Growth | 1 | 2004 | 60 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2003 | 25 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2003 | 30 | 0.010 |
Why?
|
| Adult Children | 1 | 2003 | 23 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2003 | 36 | 0.010 |
Why?
|
| Primary Health Care | 1 | 1994 | 1714 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2003 | 36 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2004 | 173 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 286 | 0.010 |
Why?
|
| Medicaid | 2 | 1999 | 433 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 2004 | 328 | 0.010 |
Why?
|
| Genetics, Population | 1 | 2004 | 210 | 0.010 |
Why?
|
| Remission Induction | 1 | 2004 | 287 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 165 | 0.010 |
Why?
|
| Monte Carlo Method | 1 | 2003 | 143 | 0.010 |
Why?
|
| Causality | 1 | 2003 | 127 | 0.010 |
Why?
|
| HLA-A Antigens | 1 | 2002 | 55 | 0.010 |
Why?
|
| Survival Rate | 1 | 2006 | 1969 | 0.010 |
Why?
|
| Morbidity | 1 | 1992 | 322 | 0.010 |
Why?
|
| Neonatal Screening | 1 | 2003 | 169 | 0.010 |
Why?
|
| United Kingdom | 1 | 2001 | 315 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2002 | 202 | 0.010 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2003 | 351 | 0.010 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 1999 | 25 | 0.010 |
Why?
|
| Haemophilus influenzae type b | 1 | 1999 | 12 | 0.010 |
Why?
|
| Haemophilus Vaccines | 1 | 1999 | 30 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 4279 | 0.010 |
Why?
|
| Poliovirus Vaccine, Inactivated | 1 | 1999 | 28 | 0.010 |
Why?
|
| Hepatitis B Vaccines | 1 | 1999 | 45 | 0.010 |
Why?
|
| Capitation Fee | 1 | 1999 | 14 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2005 | 1784 | 0.010 |
Why?
|
| Colonoscopy | 1 | 2001 | 247 | 0.010 |
Why?
|
| Office Visits | 1 | 1999 | 90 | 0.010 |
Why?
|
| Pennsylvania | 1 | 1999 | 116 | 0.010 |
Why?
|
| Fee-for-Service Plans | 1 | 1999 | 85 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2004 | 1455 | 0.010 |
Why?
|
| Platelet Count | 1 | 1998 | 86 | 0.010 |
Why?
|
| Abnormalities, Drug-Induced | 2 | 1975 | 15 | 0.010 |
Why?
|
| APACHE | 1 | 1998 | 69 | 0.010 |
Why?
|
| Acne Vulgaris | 2 | 1975 | 28 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 1998 | 150 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 1998 | 267 | 0.010 |
Why?
|
| Asbestos | 1 | 1977 | 37 | 0.010 |
Why?
|
| Population Density | 1 | 1997 | 95 | 0.010 |
Why?
|
| Cricetinae | 1 | 1977 | 288 | 0.010 |
Why?
|
| Demography | 1 | 1998 | 291 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2004 | 702 | 0.010 |
Why?
|
| Fluid Therapy | 1 | 1998 | 147 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1997 | 68 | 0.010 |
Why?
|
| Rabbits | 2 | 1975 | 789 | 0.010 |
Why?
|
| Marital Status | 1 | 1996 | 44 | 0.010 |
Why?
|
| Rats, Inbred BB | 1 | 1996 | 6 | 0.010 |
Why?
|
| Japan | 1 | 1996 | 116 | 0.010 |
Why?
|
| Genes, Immunoglobulin | 1 | 1996 | 28 | 0.010 |
Why?
|
| Information Systems | 1 | 1996 | 60 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 337 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 1998 | 523 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1996 | 154 | 0.010 |
Why?
|
| Quality Control | 1 | 1996 | 171 | 0.010 |
Why?
|
| Bronchi | 1 | 1977 | 260 | 0.010 |
Why?
|
| Hybridomas | 1 | 1996 | 237 | 0.010 |
Why?
|
| Prejudice | 1 | 1996 | 73 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1998 | 251 | 0.010 |
Why?
|
| Lupus Nephritis | 1 | 1996 | 63 | 0.010 |
Why?
|
| Marriage | 1 | 1997 | 121 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 1998 | 324 | 0.010 |
Why?
|
| Virus Diseases | 1 | 1998 | 214 | 0.010 |
Why?
|
| Polybrominated Biphenyls | 1 | 1975 | 2 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1998 | 425 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1996 | 298 | 0.010 |
Why?
|
| Bromine | 1 | 1975 | 5 | 0.010 |
Why?
|
| Halogenated Diphenyl Ethers | 1 | 1975 | 5 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1996 | 432 | 0.010 |
Why?
|
| Chemistry | 1 | 1975 | 45 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1996 | 376 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1975 | 83 | 0.010 |
Why?
|
| Erythema | 1 | 1975 | 29 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 534 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1977 | 492 | 0.010 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1975 | 77 | 0.010 |
Why?
|
| Eye | 1 | 1975 | 108 | 0.010 |
Why?
|
| Viral Proteins | 1 | 1997 | 343 | 0.010 |
Why?
|
| Neoplasms | 1 | 1989 | 2644 | 0.010 |
Why?
|
| Ligands | 1 | 1996 | 664 | 0.010 |
Why?
|
| Dioxins | 1 | 1973 | 6 | 0.010 |
Why?
|
| Poverty | 1 | 1997 | 519 | 0.010 |
Why?
|
| Reproduction | 1 | 1975 | 203 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1998 | 763 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 1999 | 548 | 0.010 |
Why?
|
| Skinfold Thickness | 1 | 1992 | 46 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1994 | 548 | 0.010 |
Why?
|
| Neutrophils | 1 | 1977 | 1234 | 0.010 |
Why?
|
| Patient Discharge | 1 | 1997 | 896 | 0.010 |
Why?
|
| Models, Molecular | 1 | 1996 | 1591 | 0.010 |
Why?
|
| Medicare | 1 | 1996 | 747 | 0.010 |
Why?
|
| Fetus | 1 | 1975 | 806 | 0.010 |
Why?
|
| Macrophages | 1 | 1977 | 1541 | 0.000 |
Why?
|
| Kidney | 1 | 1996 | 1463 | 0.000 |
Why?
|
| Lethal Dose 50 | 1 | 1973 | 15 | 0.000 |
Why?
|
| Chlorobenzenes | 1 | 1973 | 9 | 0.000 |
Why?
|
| Injections, Intraperitoneal | 1 | 1973 | 115 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1973 | 158 | 0.000 |
Why?
|
| Chickens | 1 | 1973 | 191 | 0.000 |
Why?
|
| Edema | 1 | 1973 | 129 | 0.000 |
Why?
|
| Eye Diseases | 1 | 1973 | 87 | 0.000 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 1973 | 136 | 0.000 |
Why?
|
| Fetal Diseases | 1 | 1973 | 173 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1973 | 808 | 0.000 |
Why?
|